×

img Accessibility Controls

Technologies Banner

All Technologies

Synthesis of Cetyl Myristoleate (CMO) Isomers for the Treatment of Osteoarthritis and Other Joint Inflammatory Diseases

Project Overview

Cetyl myristoleate (CMO) is the common name for hexadecyl cis-9- myristoleate. CMO is well known for its anti-arthritis properties. The main component of CMO is cis-9 myristoleic acid, and is being isolated from selective natural sources along with other fatty acids. CMO is being sold in the market for the treatment of different forms of arthritis, osteoarthritis, as well as many other forms of diseases.

Benefits

The process involves
: Preparation of Myristoleic acid from oleic/undecenoic acid
, Transesterification of Myristoleic acid with cetyl alcohol to obtain cetyl myristoleate isomers

Source

Quick Information
Thrust Areas
Medical Sciences
Focus Area
Treatment of Osteoarthritis
Source Title
Output
TRL: Technology Readiness Level
Lab Validation
Patent
CN102348482, EP2379175, US8816109
arrowtop
Latest Updates
Loading…